Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion
July 4, 2012 | BigPharma | Editor
Pharmaceutical drug maker GlaxoSmithKline PLC will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, misbranding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
Largest Pharmaceutical Misconduct Settlement In History As GSK Fined Over 3 Billion
July 4th, 2012 FAKE NEWS for the Zionist agenda